ALMB-0168
N/A
Report date: 2022/08/16 16:24:41
Base Information
Drug NameALMB-0168
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAlamab Therapeutics Inc
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesAlamab Therapeutics IncShanghai Enlemai Biotechnology Co Ltd
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A